Trinity Biotech (TRIB) EPS (Basic) (QoQ) (2009 - 2024)
Trinity Biotech (TRIB) EPS (Basic) (QoQ) (2009 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.61 Bn | 194.01 Bn | 7.27 Bn |
| 2 | Stryker | 127.81 Bn | 124.34 Bn | 4.50 Bn |
| 3 | Medtronic | 119.04 Bn | 109.82 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.68 Bn | 73.14 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.96 Bn | 47.71 Bn | 1.35 Bn |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn |
| 9 | Steris | 23.06 Bn | 22.58 Bn | 684.20 Mn |
| 10 | Trinity Biotech | 6.45 Mn | 1.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 89.70% |
| Sep 30, 2024 | -1,143.40% |
| Jun 30, 2024 | 90.14% |
| Mar 31, 2024 | -940.33% |
| Dec 31, 2023 | 95.90% |
| Sep 30, 2023 | -2,138.60% |
| Jun 30, 2023 | 94.85% |
| Mar 31, 2023 | -103.79% |
| Dec 31, 2022 | 68.18% |
| Sep 30, 2022 | -183.34% |
| Jun 30, 2022 | 83.42% |
| Mar 31, 2022 | -3,204.89% |
| Dec 31, 2021 | -123.92% |
| Sep 30, 2021 | 774.84% |
| Jun 30, 2021 | -112.22% |
| Mar 31, 2021 | 163.93% |
| Dec 31, 2020 | -134.21% |
| Sep 30, 2020 | 599.32% |
| Jun 30, 2020 | 33.98% |
| Mar 31, 2020 | -1,021,607,262.52% |